Pacira enters $300M revolving credit facility, replaces prior term loan A

Pacira BioSciences, Inc.

$300M senior secured revolver matures July 3, 2030; includes $10M LC sublimit and $15M swingline.
Proceeds used to repay and terminate existing term loan A facility; no prepayment penalties.
Interest rates: SOFR + 2.50%-3.25% or base rate + 1.50%-2.25%, based on leverage ratio.
Facility secured by substantially all assets of Pacira and subsidiary guarantors.
Incremental facility capacity up to greater of $225M or 100% Consolidated EBITDA.

item 1.01item 1.02item 2.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.